Clinical trial IONA
A non-interventional, multinational, observational study with isatuximab in patients with relapsed and/or refractory multiple myeloma (RRMM)(OBS16577) IONA
| Cancers | |
|---|---|
| Organ | Myeloma |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Prospective observational study
|
| Phase | Trial phase 4 |
| Academic trial | Non |
| Sponsor | Sanofi-Aventis |
| BECT Identifier | B0792022000001 |
| Inclusion criteria | Patients with RRMM who have received at least one prior line of therapy ; for whom the treating physician has made the decision to initiate isatuximab per routine practice and independently of the purpose of the study |
| Last update |